BioWorld Asia

Nov. 23, 2005

ExonHit Therapeutics Secures Paris Alternext Market Listing

PARIS - ExonHit Therapeutics SA became the first French biotechnology company in six years to earn a stock exchange listing. (BioWorld International) Read More

EU Seeks Ground Rules For Tissue-Engineered Products

Culture Strategy Promises Unlimited Cartilage Supplies

IntegraGen Raises EUR8M In Second Financing Round

Virologist: China Hiding Size Of Avian Flu Reach, Deaths

Pfizer Picks Candidate From NicOx, Pays EUR2M Milestone

Oxford BioMedica Brings In £30M, Searches For Partner

Nordic Biotechnology Group Emulating French Measures

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...